 MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Articles

Given the broad range of fibrocystic changes, the authors of a recent study suggest that more precise diagnosis of breast MRIs could significantly reduce unnecessary biopsy procedures. 

Redefining Fibrocystic Changes on Breast MRI: Can It Reduce the Number of Benign Biopsies?

Study findings further highlight the central role of PET/CT in disease response after CAR-T cell therapy. 

Imaging Findings May Help Detect CAR T-Cell Therapy Toxicities

Diffusion-weighted imaging may be useful as a safe and effective screening tool to supplement mammography in women with dense breast tissues. 

Diffusion-Weighted Imaging Helps Detect Breast Cancer in Dense Breasts 

PSMA PET is highly robust in identifying prostate cancer lesions which are otherwise deemed unremarkable. 

Prostate-Specific Membrane Antigen PET Bests MRI in Biochemical Recurrent Disease 

Multiparametric MRI can detect pathologic complete response after neoadjuvant therapy in patients with esophageal squamous cell carcinoma.

MRI Features Help Detect Neoadjuvant Therapy Response in Esophageal SCC

Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.  

Breast Ultrasound/MRI Fusion May Help Reduce MRI-Guided Biopsies 

The combination approach may significantly reduce over-detection while providing noninferior detection of clinically significant prostate cancer.

Stockholm3 with MRI-Targeted Biopsy Noninferior to PSA for Prostate Cancer Screening

The algorithm is the first step towards developing an artificial intelligence-augmented radiology workflow that can support image interpretation to improve diagnosis and prognosis.

Algorithm Can Classify Major Intracranial Tumor Types from a Single MRI Scan 

Training sets from different vendors may be required to ensure scanner-specific sensitivity.  

AI Can Accurately Assign Contrast Use in Prostate MRI  

Whitney J. Palmer has been with Diagnostic Imaging since 2011, serving as the Senior Editor since November 2019. She has 20 years experience in healthcare and academic medicine reporting.

The clear cell likelihood score can help providers determine the growth rate of masses that could be cancerous.

Oncology MRI